Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-04 09:51 am Purchase |
2020-12-31 | 13G | Olema Pharmaceuticals, Inc. OLMA |
WELLINGTON MANAGEMENT CO LLP | 2,069,315 5.150% |
2,069,315 (New Position) |
Filing History |
| 2020-12-03 4:06 pm Purchase |
2020-11-23 | 13D | Olema Pharmaceuticals, Inc. OLMA |
Logos Global Management LP | 3,758,818 9.400% |
3,758,818 (New Position) |
Filing History |
| 2020-11-23 4:59 pm Purchase |
2020-11-23 | 13G | Olema Pharmaceuticals, Inc. OLMA |
Cormorant Asset Management LP | 3,270,544 8.140% |
3,270,544 (New Position) |
Filing History |
| 2020-11-20 5:23 pm Purchase |
2020-11-19 | 13D | Olema Pharmaceuticals, Inc. OLMA |
BIOTECHNOLOGY VALUE FUND L P | 6,661,503 16.600% |
6,661,503 (New Position) |
Filing History |